Podcast Summary: OB/GYN Resident Survival Guide

Episode #23: Nausea & Vomiting of Pregnancy: Prevention, Management, and Something Called Neiguan's Point??

Host: Dr. KC Miller
Date: March 16, 2026

Episode Overview

This episode, hosted by Dr. KC Miller, dives deep into the prevalent and often challenging issue of nausea and vomiting of pregnancy (NVP), including hyperemesis gravidarum. Dr. Miller structures the discussion around prevention strategies, non-pharmacologic interventions, pharmacologic management, and severe cases requiring higher-level nutrition support. Listeners are offered tangible guidelines, high-yield clinical pearls, and memorable insights centered on practical management for OBGYN residents and medical students alike.

Key Discussion Points and Insights

1. Prevalence and Spectrum of NVP

• NVP is highly prevalent, affecting 50–80% of pregnant patients.
  • "It’s very likely that you will have to manage these patients in both the ambulatory setting and inpatient when people come to OB triage or when they’re admitted to the antepartum service." (01:11)
• Range of symptoms:
  • Mild: Nausea only
  • Moderate: Nausea with retching/vomiting
  • Severe: Hyperemesis gravidarum (HG)

2. Defining Hyperemesis Gravidarum (HG)

• No universal definition, but commonly identified by:
  • Persistent vomiting not attributable to other causes (e.g., GI pathology, pyelonephritis, DKA), so workup is necessary
  • Evidence of starvation (urine ketones)
  • Weight loss >5% of pre-pregnancy weight
  • Potential findings of electrolyte/endocrine imbalance (not mandatory for diagnosis)
• Quote:
  • "The first [criterion] is persistent vomiting, not related to any other causes. So of course you need to do a workup..." (02:14)

3. Etiology Theories

• Hormonal Changes: Elevations in HCG and estradiol are primary suspects, supported by:
  • Incidence increases in molar/multiple pregnancies (more HCG)
  • Lowered rates in smokers (who have reduced estradiol and HCG)
• Evolutionary adaptation:
  • "If pregnant patients have food aversions and are more sensitive to smells and tastes, then they may be less likely to consume foods that could potentially harm them and their fetus." (04:30)

4. Prevention Strategies

• Start prenatal vitamins at least one month before conception (reduces NVP incidence/severity)
  • "So get them started on a prenatal at their preconception counseling visit if you happen to catch them before they actually get pregnant." (05:50)
• Diet Modifications
  • Frequent, small meals (every 1–2 hours)
  • Bland, high-protein foods; avoid fatty/spicy items
  • Minimize sensory triggers (strong smells, bright/flickering lights, overexertion)

5. Non-Pharmacologic Interventions

• Switch prenatal vitamins:
  • Replace with folate-only supplements if nausea begins (oral iron worsens GI symptoms)
• Ginger supplements: May reduce nausea (mixed evidence)
• Acupressure at Neiguan's (P6) Point:
  • Study data are mixed, but anecdotal support exists (acupressure bands may be helpful)
  • "I have had some friends who were pregnant and really swore by those bracelets." (09:07)

6. Pharmacologic Management

First-Line:

• Vitamin B6 (pyridoxine) + doxylamine (separately or in combo)
  • "Depending on the formulation... you can start with either once a day at bedtime, up to four tablets per day." (10:03)
  • Prophylactic start in women with prior NVP may reduce the severity if symptoms develop

Second-Line:

• Dopamine antagonists:
  • Promethazine (Phenergan), metoclopramide (Reglan), prochlorperazine (Compazine)
• Antihistamines:
  • Dimenhydrinate (Dramamine), diphenhydramine (Benadryl)
  • Drowsiness common with antihistamines
  • Promethazine offers a rectal suppository option (helpful for those unable to take meds orally)
• Caution:
  • "Combining multiple dopamine antagonist medications... can increase the patient's risk for developing extrapyramidal symptoms." (12:28)

Third-Line:

• Serotonin 5HT3 receptor antagonists:
  • Ondansetron (Zofran)
  • Oral dissolvable forms available
  • Counsel on limited first-trimester data:
    • "There is some evidence that associates use during the early first trimester with congenital anomalies. Most of the evidence does not show this association." (14:16)
  • QT prolongation risk—avoid in individuals with cardiac issues or on other QT-prolonging meds

Fourth-Line:

• Steroids:
  • Methylprednisolone or prednisone (usually as a taper)
  • Risk: Weak association with first-trimester use and fetal oral clefts
  • "We basically try to save this as a last resort in patients who are less than 10 weeks gestation." (16:02)

7. Severe, Refractory Cases: Enteral and Parenteral Nutrition

• Enteral (tube feeds) preferred over TPN:
  • NG tube feeding is preferable if oral intake is impossible
  • TPN via PICC line is a last resort due to increased risks:
    • Thromboembolism (pregnancy is already hypercoagulable)
    • Sepsis from line infections
    • "TPN use in pregnancy have a much, much higher risk of morbidity, specifically from thromboembolic events and sepsis from line infections." (18:01)
    • Also, possible association with adverse neonatal outcomes (limited data)
  • Key message: Work with MFM and GI; keep TPN only for cases where tube feeding is truly impossible

Notable Quotes & Memorable Moments

• "You will manage NVP in both the ambulatory setting and inpatient... this is bread-and-butter OB but with some scary escalations." (01:17)
• "If you catch patients at preconception, prenatal vitamins a month before conceiving can help reduce NVP severity. File that under: easy wins." (05:59)
• Regarding acupressure wristbands:
  • "I have had some friends who were pregnant and really swore by those bracelets. So it’ll be interesting to see if more data does come out in support of this or if it’s just a placebo effect." (09:12)
• On treatment escalation and caution:
  • "Combining multiple dopamine antagonist medications... can increase the patient’s risk for extrapyramidal symptoms... so we should be trying to avoid those combinations when possible." (12:32)
• "Before we reach for TPN, remember the Virtos triad? Pregnancy is already hypercoagulable... you put a central line in, it’s just a bad combination." (18:25)

Timestamps for Major Segments

• 00:00–01:11: Introduction, prevalence, and clinical importance
• 01:12–03:30: Defining NVP and hyperemesis gravidarum
• 03:31–05:38: Theories of cause and evolutionary perspective
• 05:39–07:38: Prevention and dietary advice
• 07:39–09:46: Non-pharmacologic interventions (folate-only vitamins, ginger, acupressure)
• 09:47–12:32: Pharmacologic therapy: first- and second-line agents, practical tips
• 12:33–15:12: Third- and fourth-line meds, safety considerations, guideline pearls
• 15:13–18:40: Nutrition support, TPN risks, interprofessional collaboration
• 18:41–End: Rapid summary and clinical takeaways

Practical Pearls & Survival Tips

• Address NVP holistically—prevention, environment, diet, and medication all play a role.
• Stepwise escalation is key; always use the least-invasive/effective intervention first.
• Counsel patients clearly on risks and benefits, especially with ondansetron and steroids.
• Avoid TPN unless tube feeds have failed and risks of malnutrition outweigh risks of central line complications.
• Collaborate early with MFM and GI for challenging, refractory cases.

This episode equips OBGYN learners with efficient, evidence-based strategies for every stage of NVP management—delivered with Dr. Miller’s characteristic clarity, practical focus, and empathy for both trainees and patients.